Related Experiment Video
Updated: May 12, 2026

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
MicroRNA and senescence: the senectome, integration and distributed control
Alan E Bilsland1, John Revie, W Keith
1Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, UK.
Abstract:
Cellular senescence has attracted renewed interest in recent years in light of the realization that cancer cells are susceptible to senescence-like responses to stress including exposure to chemotherapeutic agents. Therefore, senescence is viewed as a potentially important target in cancer therapy. However, translation of senescence therapeutics will rely on identifying appropriate marker panels for assessing senescence responses in vivo. Although some core pathways governing senescence induction have been clearly identified, the full set of gene targets involved in its establishment and maintenance are not defined and their complex interactions are poorly understood. This view is reinforced by recently discovered roles of microRNA (miRNA) in senescence regulation and induction. Senescence involves coordination of diverse cellular processes ranging from telomere homeostasis and DNA damage to chromatin modifications, inflammatory signaling, and metabolic and cytoskeletal changes. Thus, from a target discovery perspective a "senectome" view is appropriate. miRNAs are well placed to act as distributed senectome control elements, fine-tuning regulation of multiple processes. Here, we examine the complex interactions among several of these subprocesses and subsequently consider senescence-associated miRNAs (SA-miRNAs) as distributed controllers of senectome regulation. Finally, we examine their potential as clinical biomarkers to accelerate development of senescence therapeutics.
Insights
Cellular senescence is a key target for cancer therapy, but requires better biomarkers. This study explores senescence-associated microRNAs (SA-miRNAs) as potential regulators and clinical markers for senescence therapeutics.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cellular senescence is increasingly recognized as a crucial response to stress, particularly in cancer therapy.
- Identifying reliable biomarkers for senescence in vivo is essential for developing senescence-targeted cancer treatments.
- The complex regulatory networks of senescence, including the role of microRNAs, are not fully understood.
Purpose of the Study:
- To investigate the intricate interactions within the cellular senescence network (senectome).
- To explore the role of senescence-associated microRNAs (SA-miRNAs) as regulators of the senectome.
- To evaluate the potential of SA-miRNAs as clinical biomarkers for advancing senescence-based cancer therapies.
Main Methods:
- Analysis of complex interactions among various cellular processes involved in senescence.
- Examination of senescence-associated microRNAs (SA-miRNAs) as regulatory elements.
- Assessment of SA-miRNAs for their utility as clinical biomarkers.
Main Results:
- Senescence involves a complex interplay of cellular processes, including DNA damage, chromatin modification, and inflammatory signaling.
- MicroRNAs (miRNAs) play a significant role in regulating and inducing cellular senescence.
- SA-miRNAs are identified as potential distributed controllers of senectome regulation.
Conclusions:
- Cellular senescence is a promising target in cancer therapy, necessitating robust in vivo assessment methods.
- SA-miRNAs represent a novel class of regulators within the senescence network.
- SA-miRNAs hold potential as clinical biomarkers to facilitate the development of new senescence therapeutics.
Related Concept Videos
MicroRNAs
MicroRNAs
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Translational Regulation

